Patents by Inventor Carl D. Murphy

Carl D. Murphy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5591809
    Abstract: The present invention provides novel one-step processes for preparing highly branched macromolecule polymers that have highly controlled molecular architectures. The process comprises the reaction of a branching monomer such as a substituted phenyl compound having the formula: ##STR1## wherein R.sub.1, R.sub.2, and R.sub.3 are defined herein, with a core monomer and an end-capping monomer, such as a phenolic ester, for a sufficient period of time and at a sufficient temperature to directly produce the highly branched polymer, in a single processing step.
    Type: Grant
    Filed: August 18, 1995
    Date of Patent: January 7, 1997
    Assignee: Hoechst Celanese Corporation
    Inventors: Richard Vicari, Kathleen N. Juneau, Carl D. Murphy
  • Patent number: 5567795
    Abstract: The present invention provides novel one-step processes for preparing highly branched macromolecule polymers that have highly controlled molecular architectures. The process comprise the reaction of a branching monomer such as a substituted phenyl compound having the formula: ##STR1## wherein R.sub.1, R.sub.2, and R.sub.3 are defined herein, with a second monomer (an end-capping monomer) such as a phenolic ester for a sufficient period of time and at a sufficient temperature to directly produce the highly branched polymer, in a single processing step.
    Type: Grant
    Filed: August 18, 1995
    Date of Patent: October 22, 1996
    Assignee: Hoechst Celanese Corporation
    Inventors: Richard Vicari, Kathleen N. Juneau, Carl D. Murphy
  • Patent number: 5399707
    Abstract: A process is provided whereby S(+)-ibuprofen or R(-)-ibuprofen L-lysinate salt is produced by selective precipitation from a mixture containing enantiomers of ibuprofen and L-lysine. The quantity of L-lysine is not more than about a molar equivalent of the quantity of one of the enantiomers in the ibuprofen enantiomeric mixture. Upon precipitation of one ibuprofen enantiomer from the mixture, the overall precipitate and reaction mixture can be held for a sufficient period of time at a second temperature to allow the first precipitate to redissolve into the reaction mixture and the other ibuprofen enantiomer to precipitate out of the mixture in the salt form. Optically active ibuprofen is racemized by being heated at 100.degree. C. to 300.degree. C. in the substantial absence of other materials.
    Type: Grant
    Filed: June 10, 1994
    Date of Patent: March 21, 1995
    Assignee: Hoechst Celanese Corporation
    Inventors: Apurba Bhattacharya, John R. Fritch, Carl D. Murphy, Larry D. Zeagler, Carina A. McAdams
  • Patent number: 5380867
    Abstract: A process is provided whereby S(+)-ibuprofen or R(-)-ibuprofen L-lysinate salt is produced by selective precipitation from a mixture containing enantiomers of ibuprofen and L-lysine. The quantity of L-lysine is not more than about a molar equivalent of the quantity of one of the enantiomers in the ibuprofen enantiomeric mixture. Upon precipitation of one ibuprofen enantiomer from the mixture, the overall precipitate and reaction mixture can be held for a sufficient period of time at a second temperature to allow the first precipitate to redissolve into the reaction mixture and the other ibuprofen enantiomer to precipitate out of the mixture in the salt form. Optically active ibuprofen is racemized by being heated at 100.degree. C. to 300.degree. C. in the substantial absence of other materials.
    Type: Grant
    Filed: October 19, 1993
    Date of Patent: January 10, 1995
    Assignee: Hoechst Celanese Corporation
    Inventors: Apurba Bhattacharya, John R. Fritch, Carl D. Murphy, Larry D. Zeagler, Carina A. McAdams
  • Patent number: 5332834
    Abstract: There is disclosed and claimed a process whereby S(+)-ibuprofen L-lysinate salt is produced by selective precipitation from a mixture containing enantiomers of ibuprofen and L-lysine. The quantity of L-lysine is not more than about a molar equivalent of the quantity of S(+)-ibuprofen in the ibuprofen enantiomeric mixture. The mother liquors after separating the above salt are enriched in R-ibuprofen which is racemized by a novel thermal racemization process and may then be recycled.
    Type: Grant
    Filed: December 2, 1992
    Date of Patent: July 26, 1994
    Assignee: Hoechst Celanese Corporation
    Inventors: Apurba Bhattacharya, John R. Fritch, Carl D. Murphy, Larry D. Zeagler, Carina Araullo-McAdams
  • Patent number: 4894482
    Abstract: A process is provided for removing water from a mixture of hydrogen fluoride (HF), a carboxylic acid, e.g., acetic acid, and water by extractive distillation in the presence of a Lewis base as solvent, which does not azeotrope with water, forms bonds with the HF and carboxylic acid which can be broken by heat and has a boiling point at atmospheric pressure at least about 20.degree. C. above that of the carboxylic acid, e.g., N-methyl-2-pyrrolidone, and taking off an overhead vapor comprising a major proportion of the water in said mixture. The extractive distillation may be advantageously integrated in an overall process with the production of an aromatic ketone, e.g., 4-hydroxyacetophone, by the Friedel-Crafts acylation of an aromatic compound, e.g., phenol, with the carboxylic acid, using HF as catalyst, to produce a product mixture comprising the aromatic ketone, HF, carboxylic acid and water, and the removal of aromatic ketone from the product mixture by means of a solvent assisted distillation.
    Type: Grant
    Filed: December 6, 1988
    Date of Patent: January 16, 1990
    Assignee: Hoechst Celanese Corporation
    Inventors: Daniel D. Lindley, Carl D. Murphy
  • Patent number: 4663485
    Abstract: A process is provided for the distillation of a composition containing 4-hydroxyacetophenone and hydrogen fluoride in the presence of an alkane assisting solvent having from 4 to 16 carbon atoms e.g. n-hexane or n-octane. The process is carried out to obtain an overhead vapor containing alkane solvent and most of the hydrogen fluoride in the feed, and a liquid residue containing most of the 4-hydroxyacetophenone in the feed. The overhead vapor is condensed to form two immiscible phases, one containing a preponderance of hydrogen fluoride and the other a preponderance of alkane solvent, with the latter phase being returned to the distillation as reflux. The liquid residue also separates into two immiscible layers, one containing most of the 4-hydroxyacetophenone in the feed which is recovered and the other a preponderance of alkane solvent.
    Type: Grant
    Filed: July 22, 1986
    Date of Patent: May 5, 1987
    Assignee: Celanese Corporation
    Inventors: Carl D. Murphy, Donna L. Keene, Daniel D. Lindley
  • Patent number: 4358623
    Abstract: In catalytically oxidizing methanol in the vapor phase according to already-known processes for the production of formaldehyde, the hot formaldehyde-containing gaseous effluent of the catalytic converter is rapidly cooled by being passed through the tubes of a heat exchanger which are filled with balls composed of a solid which is substantially inert toward formaldehyde. As compared with a similar cooling system in which the tubes are empty or in which enhancement of heat transfer is attempted by using metal heat-transfer enhancement devices such as twisted metal ribbons, the present method affords reduced post-reaction decomposition of formaldehyde while at the same time allowing use of a relatively high temperature on the shell side of the heat exchanger whereby it becomes possible to raise steam at a pressure higher than that characteristic of the prior art.
    Type: Grant
    Filed: July 23, 1981
    Date of Patent: November 9, 1982
    Assignee: Celanese Corporation
    Inventors: Carl D. Murphy, William P. McMillan